MeVis Medical Solutions AG has adjusted its forecast for the 2024/2025 fiscal year, based on preliminary figures for the first ten months. The company now expects revenue to decline slightly to a range of €16.5 million to €17.0 million, down from the previous forecast of €17.0 million to €17.5 million. Additionally, earnings before interest and taxes $(EBIT)$ are anticipated to decline to between €3.0 million and €3.5 million, compared to the earlier forecast of €3.5 million to €4.0 million. The adjustment is attributed to license sales being below expectations, which cannot be offset by maintenance revenues and other revenues. MeVis Medical Solutions AG continues to be a leading provider of medical imaging software.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeVis Medical Solutions AG published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: adhoc_2187294_en), on August 21, 2025, and is solely responsible for the information contained therein.